Recent developments in immunotherapy approaches for allergic rhinitis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 31

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-4)

Sum=69

Publishing Process of This Article

Item

Count

Browse

Download

Sum=1

Nov 6, 2024 (publication date) through Sep 12, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Cases. Nov 6, 2024; 12(31): 6451-6461
Published online Nov 6, 2024. doi: 10.12998/wjcc.v12.i31.6451

Table 4 Limitations of immunotherapy for allergic rhinitis

Limitation	Details	Resolution
Poor compliance with immunotherapy, which is related to gender and the number of diseases	Self-conscious inconvenience and unsatisfactory treatment effect, the compliance of children is better than that of adults	Patient education
Current SLIT guidelines are of average quality		The formulation methods and reporting standards of these guidelines must be formulated

SLIT: Sublingual immunotherapy.

Citation: Fu Y, Song YL, Liu ZG. Recent developments in immunotherapy approaches for allergic rhinitis. World J Clin Cases 2024; 12(31): 6451-6461
URL: https://www.wjgnet.com/2307-8960/full/v12/i31/6451.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i31.6451